Pediatric Immune Mediated Interstitial Lung Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pediatric Immune Mediated Interstitial Lung Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingNot Applicable

NCT07559435

Diagnostic and Prognostic Utility of IL-6 and MMP-7 in Pediatric Immune Mediated Interstitial Lung Disease

Pediatric interstitial lung disease (ILD) represents a heterogeneous group of rare but potentially severe pulmonary disorders characterized by diffuse parenchym…

Location not specified60 participantsStarted 2026-04-15

Treatment: IL-6 (interlukin 6), High-Resolution Computed Tomography (HRCT):